Cd20 Expression and Effects on Outcome of Relapsed/Refractory Diffuse Large B Cell Lymphoma after Treatment with Rituximab

INTRODUCTION: Down regulation of CD20 expression has been reported in diffuse large B cell lymphoma (DLBCL)). Therefore, it is important to determine whether chemotherapy with rituximab induces CD20 down regulation and effects survival. OBJECTIVES: To determine the incidence of down regulation of CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasheed, Afshan Asghar, Samad, Adeel, Raheem, Ahmed, Hirani, Samina Ismail, Shabbir-Moosajee, Munira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980916/
https://www.ncbi.nlm.nih.gov/pubmed/29479962
http://dx.doi.org/10.22034/APJCP.2018.19.2.331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980916/
https://www.ncbi.nlm.nih.gov/pubmed/29479962
http://dx.doi.org/10.22034/APJCP.2018.19.2.331

Ejemplares similares